Occurrence and predictors of adverse events associated with linezolid in the treatment of patients with drug resistant tuberculosis and their impact on treatment outcomes
Background: WHO recommends linezolid (LZD) for Drug-Resistant Tuberculosis (DR-TB) despite its frequent adverse events, highlighting the importance of monitoring and managing adverse drug reactions (ADRs) to prevent unfavorable treatment outcomes. This study aims to assess the frequency, severity, p...
Saved in:
| Main Authors: | Abhirami V, Jain SRK, Samta, Sainath RP |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KIMS Foundation and Research Center
2025-06-01
|
| Series: | Journal of Medical and Scientific Research |
| Subjects: | |
| Online Access: | https://jmsronline.com/archive-article/adverse-events-associated-linezolid-drug-resistant-tuberculosis |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS
by: Rinto Susilo, et al.
Published: (2025-06-01) -
Adverse effects of linezolid in the treatment of drug-resistant tuberculosis combined with diabetic peripheral neuropathy
by: Yanjun Li, et al.
Published: (2025-08-01) -
Risk Assessment of Linezolid-Associated Neurological Adverse Drug Reactions Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Yin J, et al.
Published: (2025-05-01) -
Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Mahdis Cheraghi, et al.
Published: (2025-03-01) -
Comparative analysis of efficacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)